Recombinant FVIIIFc Versus BAY 94-9027 for Treatment of Patients with Haemophilia A: Comparative Efficacy Using a Matching Adjusted Indirect Comparison
Crossref DOI link: https://doi.org/10.1007/s12325-020-01599-1
Published Online: 2020-12-30
Published Print: 2021-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hakimi, Zalmai
Santagostino, Elena
Postma, Maarten J.
Nazir, Jameel
Funding for this research was provided by:
Swedish Orphan Biovitrum AB
Text and Data Mining valid from 2020-12-30
Version of Record valid from 2020-12-30
Article History
Received: 9 October 2020
Accepted: 5 December 2020
First Online: 30 December 2020